Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hwang, Eu Chang | - |
dc.contributor.author | Hwang, Insang | - |
dc.contributor.author | Jung, Seung Il | - |
dc.contributor.author | Kang, Taek Won | - |
dc.contributor.author | Kwon, Dong Deuk | - |
dc.contributor.author | Heo, Suk Hee | - |
dc.contributor.author | Hwang, Jun Eul | - |
dc.contributor.author | Kang, Sung Gu | - |
dc.contributor.author | Kang, Seok Ho | - |
dc.contributor.author | Lee, Jeong Gu | - |
dc.contributor.author | Kim, Je Jong | - |
dc.contributor.author | Cheon, Jun | - |
dc.date.accessioned | 2021-09-05T08:44:15Z | - |
dc.date.available | 2021-09-05T08:44:15Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-05-23 | - |
dc.identifier.issn | 1471-2490 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/98497 | - |
dc.description.abstract | Background: The survival benefits of adrenalectomy (ADx) in the setting of metastatic cancer and prognostic factors for recurrence-free (RFS) and overall survival (OS) after adrenalectomy for metastatic carcinoma are still under debate. We evaluated the impact of clinicopathological variables on RFS and OS after ADx for metastatic carcinoma in patients with primary cancer. Methods: A total of 32 patients undergoing ADx for metastatic cancer between 2004 and 2012 at two tertiary medical centers. Metastases were regarded as synchronous (<6 months) or metachronous (>= 6 months) depending on the interval after primary surgery. Associations of perioperative clinicopathologic variables with RFS and OS were analyzed using Cox regression models. Results: In total, 32 patients received ADx for metastatic primary tumors located in the lung (n = 11), colon (n = 4), liver (n = 5), stomach (n = 3), kidney (n = 4), pancreas (n = 2), glottis, esophagus, cervix, and ovary (n = 1 each). The overall recurrence rate after adrenalectomy was 62.5% (n = 20). By univariate analysis, C-reactive protein, inflammation-based prognosis score, and adrenalectomy for curative intent were associated with RFS and OS. Independent prognostic factors for shorter RFS were operative method (laparoscopy HR 4.68, 95% CI 1.61-13.61, p = 0.005) and inflammation-based prognostic score (HR 11.8, 95% CI 2.50-55.7, p = 0.002). For shorter OS, synchronous metastasis (HR 3.05, 95% CI 1.07-11.94, p = 0.048) and inflammation-based prognostic score (HR 6.65, 95% CI 1.25-35.23, p = 0.026) were identified as independent prognostic factors. Conclusions: Our pilot study suggests that synchronous disease and inflammation-based prognostic score are significant prognostic factors for survival and should be considered when performing ADx for metastatic diseases. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | BIOMED CENTRAL LTD | - |
dc.subject | SYSTEMIC INFLAMMATORY RESPONSE | - |
dc.subject | CELL LUNG-CANCER | - |
dc.subject | COLORECTAL-CANCER | - |
dc.subject | LAPAROSCOPIC ADRENALECTOMY | - |
dc.subject | SCORE GPS | - |
dc.subject | RESECTION | - |
dc.subject | OUTCOMES | - |
dc.subject | GLANDS | - |
dc.title | Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kang, Sung Gu | - |
dc.contributor.affiliatedAuthor | Kang, Seok Ho | - |
dc.contributor.affiliatedAuthor | Lee, Jeong Gu | - |
dc.contributor.affiliatedAuthor | Kim, Je Jong | - |
dc.contributor.affiliatedAuthor | Cheon, Jun | - |
dc.identifier.doi | 10.1186/1471-2490-14-41 | - |
dc.identifier.scopusid | 2-s2.0-84901695649 | - |
dc.identifier.wosid | 000336749600001 | - |
dc.identifier.bibliographicCitation | BMC UROLOGY, v.14 | - |
dc.relation.isPartOf | BMC UROLOGY | - |
dc.citation.title | BMC UROLOGY | - |
dc.citation.volume | 14 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | SYSTEMIC INFLAMMATORY RESPONSE | - |
dc.subject.keywordPlus | CELL LUNG-CANCER | - |
dc.subject.keywordPlus | COLORECTAL-CANCER | - |
dc.subject.keywordPlus | LAPAROSCOPIC ADRENALECTOMY | - |
dc.subject.keywordPlus | SCORE GPS | - |
dc.subject.keywordPlus | RESECTION | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | GLANDS | - |
dc.subject.keywordAuthor | Adrenalectomy | - |
dc.subject.keywordAuthor | Neoplasm metastasis | - |
dc.subject.keywordAuthor | Prognosis | - |
dc.subject.keywordAuthor | Survival | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.